FCI
VKTX icon

Financial Counselors Inc’s Viking Therapeutics VKTX Stock Holding History

Financial Counselors Inc’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,476
Closed -$1.34M – 519
2025
Q1 		$1.34M Buy
55,476
+16,823
+44% +$532K 0.02% 302
2024
Q4 		$1.56M Sell
38,653
-7,328
-16% -$418K 0.02% 292
2024
Q3 		$2.91M Buy
+45,981
New +$2.7M 0.04% 247

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Financial Counselors Inc's VKTX Position: Q2 2025 in Review

Financial Counselors Inc sold out of Viking Therapeutics (VKTX) in Q2 2025, closing a stake of 55,476 shares — an estimated $1.34M sold.

Financial Counselors Inc first reported a position in VKTX in Q3 2024 and held it in 3 quarters. The position peaked at $2.91M in Q3 2024. 391 funds tracked by Wall St. Rank hold VKTX as of Q2 2025.

  • Financial Counselors Inc reported no remaining Viking Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Financial Counselors Inc sold 55,476 Viking Therapeutics shares in Q2 2025, an estimated $1.34M.
  • Financial Counselors Inc first reported a position in Viking Therapeutics in Q3 2024 and held it in 3 quarters.
  • Financial Counselors Inc's Viking Therapeutics position peaked at $2.91M in Q3 2024.
  • 391 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2025.

Based on Financial Counselors Inc's 13F filing for Q2 2025, filed 1 Aug 2025.